U.S. Advisers Say ‘No’ to Routine PSA Tests for Prostate Cancer

<p>MONDAY, May 21 (HealthDay News) In a frequency expected move
sure to unleash exhilarated debate, a distinguished U.S. supervision advisory panel
is recommending that organisation of all ages no longer be screened for prostate
cancer by undergoing a prostate-specific antigen (PSA) blood test.
The U.S. Preventive Services Task Force, an eccentric organisation of
medical experts in impediment and evidence-based medicine, pronounced PSA
screening formula in overdiagnosis of prostate cancer and unnecessary
treatment that can leave organisation insufficient and incontinent.
This final recommendation comes 7 months after a task force
drafted a news giving a D rating for a PSA blood test. Previous
guidelines had settled that many organisation should bear screening commencement at
age 50.
Some might contend that by rating a exam a D were holding divided the
possibility of an sensitive decision, though we dont wish that to be the
case, pronounced task force co-vice chair Dr. Michael L...